Pharmaceutical Industry discussion, review, analysis, news and information.

The FDA has approved the use of Lamisil Oral Granules in the treatment of scalp ringworm, tinea capitis, in children over the age of 4.

"Tinea capitis is a persistent infection that is hard to treat, and one that causes children embarrassment," said Steven Galson, M.D., M.P.H., director of FDA's Center for Drug Evaluation and Research. "A parent's ability to sprinkle it on the food of a child, who may not like to take medicine, should go a long way to helping ensure the infection is properly treated and to limiting its spread."

Lamisil is a Novartis Pharmaceuticals product. The company was approached by the FDA for a formulation that would appeal to children. Novartis developed the granules which can be sprinkled on food.